Zuffa releases statement on Ali Bagautinov

After Ali Bagautinov was determined to have failed his drug test before UFC 174, Zuffa released the below statement on the top flyweight contender.

“UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO).  He was also informed that his positive test violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC.  The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes.  Bagautinov will serve a one-year suspension and must pass a drug test at the conclusion of his suspension before receiving clearance to compete in the UFC again.”

UFC president Dana White told Yahoo he was “beyond disappointed’ over the Bagautinov news.

“We’re not paying lip service to this,” White said. “We’re trying to clean this up. It’s hurting everyone in the sport and we’re all over it.”

After Ali Bagautinov was determined to have failed his drug test before UFC 174, Zuffa released the below statement on the top flyweight contender.

“UFC 174 competitor Ali Bagautinov has been suspended by the British Columbia Athletic Commission for testing positive for erythropoietin (EPO).  He was also informed that his positive test violated the UFC Fighter Conduct Policy and Promotional Agreement with Zuffa, LLC.  The UFC has a strict, consistent policy against the use of any illegal and/or performance-enhancing drugs, stimulants or masking agents by our athletes.  Bagautinov will serve a one-year suspension and must pass a drug test at the conclusion of his suspension before receiving clearance to compete in the UFC again.”

UFC president Dana White told Yahoo he was “beyond disappointed’ over the Bagautinov news.

“We’re not paying lip service to this,” White said. “We’re trying to clean this up. It’s hurting everyone in the sport and we’re all over it.”